ClinicalTrials.gov
ClinicalTrials.gov Menu

A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00057525
Recruitment Status : Completed
First Posted : April 7, 2003
Last Update Posted : June 30, 2011
Sponsor:
Information provided by:
DynPort Vaccine Company LLC, A CSC Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2004
  Actual Study Completion Date : August 2004